← Insider buys
UTHR

United Therapeutics Corporation · Healthcare

Chair and CEO Martine A Rothblatt sold $5.1M of United Therapeutics Corporation

Sold$5,145,537
$541.64Price
9,500Shares
−3%Stake

What UTHR did after the filing

Filed Oct 6Copier in Oct 7
The stock from Wed, Oct 7 open, $542.41
+0.1%
S&P 500, same days
−1.2%

8 of 30 trading days so far, to the Oct 19 close.

Traded Mon, Oct 5. Filed Tue, Oct 6, 4:32 PM ET, after the close. Returns use the Oct 7 open and the Oct 19 close. Not investment advice.